inhibitors

Cure for prostate cancer on the horizon

(PRESS RELEASE) FREIBURG, Germany, 1-Jul-2021 — /EuropaWire/ — Prostate cancer is the second most common cancer. According to the American…

3 years ago

Technical University of Munich scientists described a new class of designed macrocyclic peptides that are highly potent inhibitors of amyloid formation

MUNICH, 14-Aug-2018 — /EuropaWire/ — Effective therapeutics to counteract the formation of amyloid plaques in Alzheimer's disease and type 2 diabetes…

6 years ago

Roche: US FDA granted Breakthrough Therapy Designation to Hemlibra® for people with haemophilia A without factor VIII inhibitors

Designation based on phase III HAVEN 3 study demonstrating Hemlibra prophylaxis significantly reduced bleeds compared to no prophylaxis First medicine…

6 years ago